Teranode Launches First Model Server to Accelerate Collaboration in Life Sciences R&D
Teranode Corporation, the leading innovator of design automation software for the Life Sciences industry, today announced the immediate availability of the TERANODE Model Server. The TERANODE Model Server is the industry’s first server to provide a single repository for the entire study and research process, managing design through protocol development and experimentation to evaluation. (See also today’s press releases entitled,”Teranode Unveils First Closed-Loop R&D Platform for the Life Sciences Industry” and “Teranode Announces Accelerator Integration Kit for Innovative Closed-Loop R&D Solutions.”)
Previous to this new technology, organizations did not have efficient solutions for building and sharing biological and protocol models, driving research staff to plan and execute Life Sciences studies and research using ad-hoc office tools and math modeling programs, documenting protocols with standard word processing applications, and gathering data on spreadsheets. Often times, final analyses were then performed using even other applications and databases. The result was a fragmented informatics landscape throttling the speed of collaboration. The TERANODE Model Server is a comprehensive, flexible server solution that allows research organizations to conduct and manage research processes from a single source, greatly streamlining and accelerating the overall research process, as well as improving the quality of research data and the responsiveness of research teams.
Dr. Paul Johnson, senior vice president of R&D and chief science officer for Nastech Pharmaceutical Company has realized significant gains and notes, “The TERANODE Model Server was chosen to link our peptide production and phage display groups together to accelerate our research. Using a common repository, the quality of our experimental data can be improved as well as the responsiveness of our research organization.”
TERANODE Model Server Provides Competitive Advantage
Research and biology staff can take immediate advantage of the TERANODE Model Server to streamline and accelerate overall research processes. Teranode’s new technology extends TERANODE Design Suite’s comprehensive services to workgroups and enterprise processes. These powerful features provide competitive advantage by significantly accelerating the research cycle, allowing Life Sciences companies to get their products to market more quickly. Key features of the TERANODE Model Server include:
| Single Repository For the first time, the TERANODE Model Server allows researchers the ability to store biological and protocol models in the same repository as experimental data used to evaluate study results and validate biological models. |
|
| Model and Dataset Integrity New “check-in” and “check-out” controls ensure that the integrity of models and datasets are maintained in a multi-user environment. |
|
| Search and Datamining With the TERANODE Model Server, models and datasets can be clustered and organized by categories, then navigated visually using those same categories. |
|
| Records Management Teranode’s Model Server technology allows all models and datasets to be marked as records, which blocks any attempt to modify or delete the model or dataset. |
“Until now, researchers relied on a broad range of software tools and methods to store data and model information,” said Joseph Duncan, CEO of Teranode. “However, most scientists would agree that cobbling together a slew of office programs and math tools is a very inefficient way to collaborate. The TERANODE Model Server brings Life Sciences into the 21st century by providing a common repository that covers the entire study and research lifecycle.”
Pricing and Availability
Pricing for the TERANODE Model Server begins at $25,000 per CPU. Special academic pricing begins at $12,500 per CPU. The TERANODE Model Server is available immediately for purchase. For additional pricing information, please email sales@teranode.com .
About Teranode Corporation
Teranode Corporation, headquartered in Seattle, WA, delivers a design automation platform that unifies the planning, execution, and evaluation of physical and in-silico processes. The company, founded in 2002 to revolutionize the role that computing plays in Life Sciences, began with technologies invented by the founders at the University of Washington.
The company has been backed during its formative stage by research partners including the University of Washington, Intel, the NSF and the NIH. It is an IBM Business Partner in the Life Sciences sector and an Oracle Advantage Partner. The company’s Design Suite is being used by leading pharmaceutical, biotechnology, research, and academic organizations including Pfizer, AstraZeneca, St. Jude’s Hospital, and Fred Hutchinson Cancer Research Center. Visit the company’s web site at: www.teranode.com .






